Details for Patent: 11,426,404
✉ Email this page to a colleague
Which drugs does patent 11,426,404 protect, and when does it expire?
Patent 11,426,404 protects LUMAKRAS and is included in one NDA.
This patent has twenty patent family members in thirteen countries.
Summary for Patent: 11,426,404
Title: | Dosing of KRAS inhibitor for treatment of cancers |
Abstract: | Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject. |
Inventor(s): | Henary; Haby (Moorpark, CA), Lipford; James Russell (Thousand Oaks, CA), Cee; Victor J. (Thousand Oaks, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 15/930,606 |
Patent Claim Types: see list of patent claims | Use; Delivery; Dosage form; |
Drugs Protected by US Patent 11,426,404
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen Inc | LUMAKRAS | sotorasib | TABLET;ORAL | 214665-001 | May 28, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ADULT PATIENTS WITH KRAS G12C-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC), AS DETERMINED BY AN FDA-APPROVED TEST, WHO HAVE RECEIVED AT LEAST ONE PRIOR SYSTEMIC THERAPY | ⤷ Try a Trial | ||||
Amgen Inc | LUMAKRAS | sotorasib | TABLET;ORAL | 214665-002 | Jan 20, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ADULT PATIENTS WITH KRAS G12C-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC), AS DETERMINED BY AN FDA-APPROVED TEST, WHO HAVE RECEIVED AT LEAST ONE PRIOR SYSTEMIC THERAPY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,426,404
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 118933 | ⤷ Try a Trial | |||
Australia | 2020275845 | ⤷ Try a Trial | |||
Canada | 3139519 | ⤷ Try a Trial | |||
China | 113840606 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 202193113 | ⤷ Try a Trial | |||
European Patent Office | 3738593 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |